Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors

K. A. Garbett, A. Vereczkei, S. Kálmán, L. Wang, Zeljka Korade, R. C. Shelton, Karoly Mirnics

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Major depressive disorder (MDD) is increasingly viewed as interplay of environmental stressors and genetic predisposition, and recent data suggest that the disease affects not only the brain, but the entire body. As a result, we aimed at determining whether patients with major depression have aberrant molecular responses to stress in peripheral tissues. We examined the effects of two metabolic stressors, galactose (GAL) or reduced lipids (RL), on the transcriptome and miRNome of human fibroblasts from 16 pairs of patients with MDD and matched healthy controls (CNTR). Our results demonstrate that both MDD and CNTR fibroblasts had a robust molecular response to GAL and RL challenges. Most importantly, a significant part (messenger RNAs (mRNAs): 26-33%; microRNAs (miRNAs): 81-90%) of the molecular response was only observed in MDD, but not in CNTR fibroblasts. The applied metabolic challenges uncovered mRNA and miRNA signatures, identifying responses to each stressor characteristic for the MDD fibroblasts. The distinct responses of MDD fibroblasts to GAL and RL revealed an aberrant engagement of molecular pathways, such as apoptosis, regulation of cell cycle, cell migration, metabolic control and energy production. In conclusion, the metabolic challenges evoked by GAL or RL in dermal fibroblasts exposed adaptive dysfunctions on mRNA and miRNA levels that are characteristic for MDD. This finding underscores the need to challenge biological systems to bring out disease-specific deficits, which otherwise might remain hidden under resting conditions.

Original languageEnglish (US)
Article numberA523
JournalTranslational Psychiatry
Volume5
Issue number3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Major Depressive Disorder
Fibroblasts
Galactose
MicroRNAs
Lipids
Messenger RNA
Genetic Predisposition to Disease
Transcriptome
Cell Movement
Cell Cycle
Depression
Apoptosis
Skin
Brain

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Cite this

Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors. / Garbett, K. A.; Vereczkei, A.; Kálmán, S.; Wang, L.; Korade, Zeljka; Shelton, R. C.; Mirnics, Karoly.

In: Translational Psychiatry, Vol. 5, No. 3, A523, 01.01.2015.

Research output: Contribution to journalArticle

@article{cc5e8bae81ca4addade6042fc9de2e9e,
title = "Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors",
abstract = "Major depressive disorder (MDD) is increasingly viewed as interplay of environmental stressors and genetic predisposition, and recent data suggest that the disease affects not only the brain, but the entire body. As a result, we aimed at determining whether patients with major depression have aberrant molecular responses to stress in peripheral tissues. We examined the effects of two metabolic stressors, galactose (GAL) or reduced lipids (RL), on the transcriptome and miRNome of human fibroblasts from 16 pairs of patients with MDD and matched healthy controls (CNTR). Our results demonstrate that both MDD and CNTR fibroblasts had a robust molecular response to GAL and RL challenges. Most importantly, a significant part (messenger RNAs (mRNAs): 26-33{\%}; microRNAs (miRNAs): 81-90{\%}) of the molecular response was only observed in MDD, but not in CNTR fibroblasts. The applied metabolic challenges uncovered mRNA and miRNA signatures, identifying responses to each stressor characteristic for the MDD fibroblasts. The distinct responses of MDD fibroblasts to GAL and RL revealed an aberrant engagement of molecular pathways, such as apoptosis, regulation of cell cycle, cell migration, metabolic control and energy production. In conclusion, the metabolic challenges evoked by GAL or RL in dermal fibroblasts exposed adaptive dysfunctions on mRNA and miRNA levels that are characteristic for MDD. This finding underscores the need to challenge biological systems to bring out disease-specific deficits, which otherwise might remain hidden under resting conditions.",
author = "Garbett, {K. A.} and A. Vereczkei and S. K{\'a}lm{\'a}n and L. Wang and Zeljka Korade and Shelton, {R. C.} and Karoly Mirnics",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/tp.2015.14",
language = "English (US)",
volume = "5",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors

AU - Garbett, K. A.

AU - Vereczkei, A.

AU - Kálmán, S.

AU - Wang, L.

AU - Korade, Zeljka

AU - Shelton, R. C.

AU - Mirnics, Karoly

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Major depressive disorder (MDD) is increasingly viewed as interplay of environmental stressors and genetic predisposition, and recent data suggest that the disease affects not only the brain, but the entire body. As a result, we aimed at determining whether patients with major depression have aberrant molecular responses to stress in peripheral tissues. We examined the effects of two metabolic stressors, galactose (GAL) or reduced lipids (RL), on the transcriptome and miRNome of human fibroblasts from 16 pairs of patients with MDD and matched healthy controls (CNTR). Our results demonstrate that both MDD and CNTR fibroblasts had a robust molecular response to GAL and RL challenges. Most importantly, a significant part (messenger RNAs (mRNAs): 26-33%; microRNAs (miRNAs): 81-90%) of the molecular response was only observed in MDD, but not in CNTR fibroblasts. The applied metabolic challenges uncovered mRNA and miRNA signatures, identifying responses to each stressor characteristic for the MDD fibroblasts. The distinct responses of MDD fibroblasts to GAL and RL revealed an aberrant engagement of molecular pathways, such as apoptosis, regulation of cell cycle, cell migration, metabolic control and energy production. In conclusion, the metabolic challenges evoked by GAL or RL in dermal fibroblasts exposed adaptive dysfunctions on mRNA and miRNA levels that are characteristic for MDD. This finding underscores the need to challenge biological systems to bring out disease-specific deficits, which otherwise might remain hidden under resting conditions.

AB - Major depressive disorder (MDD) is increasingly viewed as interplay of environmental stressors and genetic predisposition, and recent data suggest that the disease affects not only the brain, but the entire body. As a result, we aimed at determining whether patients with major depression have aberrant molecular responses to stress in peripheral tissues. We examined the effects of two metabolic stressors, galactose (GAL) or reduced lipids (RL), on the transcriptome and miRNome of human fibroblasts from 16 pairs of patients with MDD and matched healthy controls (CNTR). Our results demonstrate that both MDD and CNTR fibroblasts had a robust molecular response to GAL and RL challenges. Most importantly, a significant part (messenger RNAs (mRNAs): 26-33%; microRNAs (miRNAs): 81-90%) of the molecular response was only observed in MDD, but not in CNTR fibroblasts. The applied metabolic challenges uncovered mRNA and miRNA signatures, identifying responses to each stressor characteristic for the MDD fibroblasts. The distinct responses of MDD fibroblasts to GAL and RL revealed an aberrant engagement of molecular pathways, such as apoptosis, regulation of cell cycle, cell migration, metabolic control and energy production. In conclusion, the metabolic challenges evoked by GAL or RL in dermal fibroblasts exposed adaptive dysfunctions on mRNA and miRNA levels that are characteristic for MDD. This finding underscores the need to challenge biological systems to bring out disease-specific deficits, which otherwise might remain hidden under resting conditions.

UR - http://www.scopus.com/inward/record.url?scp=84981194461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981194461&partnerID=8YFLogxK

U2 - 10.1038/tp.2015.14

DO - 10.1038/tp.2015.14

M3 - Article

VL - 5

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 3

M1 - A523

ER -